217 related articles for article (PubMed ID: 37430331)
1. Prognosis and local treatment strategies of breast cancer patients with different numbers of micrometastatic lymph nodes.
Luo S; Fu W; Lin J; Zhang J; Song C
World J Surg Oncol; 2023 Jul; 21(1):202. PubMed ID: 37430331
[TBL] [Abstract][Full Text] [Related]
2. An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodes.
Ren F; Yang C; Liu J; Feng K; Shang Q; Kang X; Zhang R; Li L; Zhao S; Wang X; Wang X
Transl Cancer Res; 2024 Feb; 13(2):935-951. PubMed ID: 38482409
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: A competing risk analysis using the SEER database.
Zhou Y; Pu S; Jiang S; Li D; Li S; Liu Y; Ren Y; Hao N
Front Oncol; 2022; 12():1012646. PubMed ID: 36465338
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
[TBL] [Abstract][Full Text] [Related]
5. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
[TBL] [Abstract][Full Text] [Related]
6. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
[TBL] [Abstract][Full Text] [Related]
7. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy.
Lim SZ; Kusumawidjaja G; Mohd Ishak HM; Tan BKT; Tan SY; Hamzah JL; Madhukumar P; Yong WS; Wong CY; Sim Y; Lim GH; Lim SH; Tan SM; Wong FY; Tan VKM
Breast Cancer Res Treat; 2021 Oct; 189(3):837-843. PubMed ID: 34342766
[TBL] [Abstract][Full Text] [Related]
9. Association of Axillary Lymph Node Evaluation With Survival in Women Aged 70 Years or Older With Breast Cancer.
Luo SP; Zhang J; Wu QS; Lin YX; Song CG
Front Oncol; 2020; 10():596545. PubMed ID: 33585213
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study.
Tvedskov TF; Jensen MB; Ejlertsen B; Christiansen P; Balslev E; Kroman N
Breast Cancer Res Treat; 2015 Oct; 153(3):599-606. PubMed ID: 26341752
[TBL] [Abstract][Full Text] [Related]
11. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.
Chun JW; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
Sci Rep; 2021 Apr; 11(1):9056. PubMed ID: 33907236
[TBL] [Abstract][Full Text] [Related]
13. Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer.
Li P; Yang C; Zhang J; Chen Y; Zhang X; Liang M; Huang N; Chen Y; Wang K
Oncologist; 2023 Aug; 28(8):e591-e599. PubMed ID: 36929946
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
15. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Mann JM; Wu X; Christos P; Nagar H
Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
[TBL] [Abstract][Full Text] [Related]
16. Axillary treatment for operable primary breast cancer.
Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
[TBL] [Abstract][Full Text] [Related]
17. The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study.
Li S; Liu F; Chen K; Rao N; Xie Y; Su F; Zhu L
Medicine (Baltimore); 2016 Apr; 95(14):e3254. PubMed ID: 27057872
[TBL] [Abstract][Full Text] [Related]
18. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study.
Yang H; Sun Y; Wang P; Qiao J; Wang C; Liu Z
Clin Breast Cancer; 2024 Apr; 24(3):e126-e137.e3. PubMed ID: 38114365
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer.
Rovera F; Fachinetti A; Rausei S; Chiappa C; Lavazza M; Arlant V; Marelli M; Boni L; Dionigi G; Dionigi R
Int J Surg; 2013; 11 Suppl 1():S73-8. PubMed ID: 24380559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]